RAINBOW: A GLOBAL, PHASE 3, DOUBLE-BLIND STUDY OF RAMUCIRUMAB (RAM) PLUS PACLITAXEL (PTX) VERSUS PLACEBO (PL) plus PTX IN THE TREATMENT OF ADVANCED GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA FOLLOWING DISEASE PROGRESSION ON FIRST-LINE PLATINUM- AND FLUOROPYRIMIDINE-CONTAINING COMBINATION THERAPY: A SUBGROUP ANALYSIS OF WESTERN POPULATION

被引:0
作者
Wilke, Hansjochen [1 ]
Clingan, Philip [2 ]
Ananda, Sumi [3 ]
Kurteva, Galina [4 ]
Suuroja, Tiit [5 ]
Folprecht, Gunnar [6 ]
Beny, Alexander [7 ]
Pastorelli, Davide [8 ]
Cesas, Alvydas [9 ]
Nowecki, Zbigniew [10 ]
Toganel, Cornelia [11 ]
Bodoky, Gyoergy [12 ]
Lipatov, Oleg [13 ]
Miron, Maria Limon [14 ]
Cunningham, David [15 ]
Cummins, Sebastian [16 ]
Wainberg, Zev [17 ]
Ko, Andrew [18 ]
Emig, Michael [19 ]
Chandrawansa, Kumari [20 ]
van Cutsem, Eric [21 ]
机构
[1] Kliniken Essen Mitte, Essen, Germany
[2] Southern Med Day Care Ctr, Wollongong, NSW, Australia
[3] Western Hlth, Melbourne, Vic, Australia
[4] Specialised Hosp Act Treatment Oncol, Sofia, Bulgaria
[5] North Estonia Med Ctr, Tallinn, Estonia
[6] Univ Klinikum Carl Gustav Carus, Dresden, Germany
[7] Rambam Hlth Care Campus, Haifa, Israel
[8] Ist Oncol Veneto IRCCS, Padua, Italy
[9] Klaipeda Univ Hosp, Klaipeda, Lithuania
[10] Ctr Onkol Inst M Sklodowskiej Curie, Warsaw, Poland
[11] Spitalul Clin Judetean Mures, Targu Mures, Romania
[12] St Laszlo Hosp, Dept Oncol, Budapest, Hungary
[13] Republican Clin Oncol Dispensary, Ufa, Russia
[14] HUV Rocio, Seville, Spain
[15] Royal Marsden Hosp, London SW3 6JJ, England
[16] Royal Surrey Cty Hosp, Guildford, Surrey, England
[17] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA
[18] Univ Calif San Francisco, San Francisco, CA 94143 USA
[19] Eli Lilly & Co, Homburg, Germany
[20] Eli Lilly & Co, Indianapolis, IN 46285 USA
[21] Univ Hosp Gasthuisberg Leuven, Leuven, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
362
引用
收藏
页码:171 / 171
页数:1
相关论文
共 45 条
[41]   East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL) [J].
Park, Keunchil ;
Kim, Joo-Hang ;
Cho, Eun Kyung ;
Kang, Jin-Hyoung ;
Shih, Jin-Yuan ;
Zimmermann, Annamaria Hayden ;
Lee, Pablo ;
Alexandris, Ekaterine ;
Puri, Tarun ;
Orlando, Mauro .
CANCER RESEARCH AND TREATMENT, 2016, 48 (04) :1177-1186
[43]   REVEL: A randomized, double-blind, phase III study of docetaxel (DOC) and ramucirumab (RAM; IMC-1121B) versus DOC and placebo (PL) in the second-line treatment of stage IV non-small cell lung cancer (NSCLC) following disease progression after one prior platinum-based therapy [J].
Perol, Maurice ;
Ciuleanu, Tudor-Eliade ;
Arrieta, Oscar ;
Prabhash, Kumar ;
Syrigos, Konstantinos N. ;
Goeksel, Tuncay ;
Park, Keunchli ;
Kowalyszyn, Ruben Carlo ;
Pikiel, Joanna ;
Czyzewicz, Grzegorz ;
Oriov, Sergey ;
Lewanski, Conrad R. ;
Alexandris, Ekaterine ;
Zimmerman, Annemaria ;
Chouaki, Nadia ;
John, William J. ;
Yurasov, Sergey ;
Garon, Edward B. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[44]   REVEL: A randomized, double-blind, phase III study of docetaxel (DOC) and ramucirumab (RAM; IMC-1121B) versus DOC and placebo (PL) in the second-line treatment of stage IV non-small cell lung cancer (NSCLC) following disease progression after one prior platinum-based therapy. [J].
Perol, Maurice ;
Ciuleanu, Tudor-Eliade ;
Arrieta, Oscar ;
Prabhash, Kumar ;
Syrigos, Konstantinos N. ;
Goksel, Tuncay ;
Park, Keunchil ;
Kowalyszyn, Dario ;
Pikiel, Joanna ;
Czyzewicz, Grzegorz ;
Orlov, Sergey ;
Lewanski, Conrad R. ;
Alexandris, Ekaterine ;
Zimmerman, Annamaria ;
Chouaki, Nadia ;
John, William J. ;
Yurasov, Sergey ;
Garon, Edward B. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18)
[45]   Management of nausea and vomiting (N/V) following first-line (1L) zolbetuximab plus chemotherapy treatment in claudin-18.2 (CLDN18.2)+, HER2-, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Analysis from the phase 3 SPOTLIGHT and GLOW studies. [J].
Shitara, Kohei ;
Pophale, Rupesh ;
Matsangou, Maria ;
Park, Jung Wook ;
Oh, Mok ;
Bhattacharya, Pranob P. ;
Ranganath, Radhika .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) :372-372